NRF2 as a Therapeutic Target in Neurodegenerative Diseases
NRF2 как терапевтическая мишень при нейродегенеративных заболеваниях
2020-01-01
SCID: 54.1/qqrp9383
Discuss with AI
NRF2NRF2 activatorsneurodegenerative diseasesneuroinflammationoxidative stress
Figures from the paper
Abstract (AI)
Increased reactive oxygen species production and oxidative stress have been implicated in the pathogenesis of numerous neurodegenerative conditions including among others Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Friedrich’s ataxia, multiple sclerosis, and stroke. The endogenous antioxidant response pathway protects cells from oxidative stress by increasing the expression of cytoprotective enzymes and is regulated by the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2). In addition to regulating the expression of antioxidant genes, NRF2 has also been shown to exert anti-inflammatory effects and modulate both mitochondrial function and biogenesis. This is because mitochondrial dysfunction and neuroinflammation are features of many neurodegenerative diseases as well NRF2 has emerged as a promising therapeutic target. Here, we review evidence for a beneficial role of NRF2 in neurodegenerative conditions and the potential of specific NRF2 activators as therapeutic agents.
Key Findings
1
Because mitochondrial dysfunction and neuroinflammation are common features of neurodegenerative diseases, NRF2 has emerged as a promising therapeutic target.
2
Beyond antioxidant gene regulation, NRF2 exerts anti-inflammatory effects and modulates mitochondrial function and biogenesis.
3
Evidence supporting NRF2’s beneficial role and the therapeutic potential of specific NRF2 activators is reviewed across neurodegenerative conditions.
4
NRF2 regulates endogenous antioxidant responses by inducing cytoprotective enzyme expression, thereby protecting cells from oxidative stress.
5
Oxidative stress and increased reactive oxygen species production are implicated in the pathogenesis of multiple neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s diseases.
Research Object
NRF2 in neurodegenerative diseases
Research Subject
The therapeutic potential and beneficial effects of NRF2 activation, including antioxidant, anti-inflammatory, and mitochondrial regulatory functions
Publication Details
Publication Date
2020-01-01
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest